Niagen Bioscience (NAGE) Cash from Operations (QoQ) (2011 - 2026)
Niagen Bioscience (NAGE) Cash from Operations (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -269.60% |
| Dec 31, 2025 | -80.97% |
| Sep 30, 2025 | 204.03% |
| Jun 30, 2025 | -84.56% |
| Mar 31, 2025 | -8.16% |
| Dec 31, 2024 | 145.58% |
| Sep 30, 2024 | 1,423.86% |
| Jun 30, 2024 | -189.49% |
| Mar 31, 2024 | -54.55% |
| Dec 31, 2023 | 63.89% |
| Sep 30, 2023 | -87.93% |
| Jun 30, 2023 | 17.48% |
| Mar 31, 2023 | 951.22% |
| Dec 31, 2022 | 91.23% |
| Sep 30, 2022 | 2.40% |
| Jun 30, 2022 | 46.76% |
| Mar 31, 2022 | -45.59% |
| Dec 31, 2021 | 16.47% |
| Sep 30, 2021 | 25.03% |
| Jun 30, 2021 | -46.07% |